Spectral-Domain OCT Analyses of Macular Changes After Ranibizumab Therapy for Type 1 Retinopathy of Prematurity

EROL, Muhammet; COBAN, Deniz; OZDEMIR, Ozdemir; TUNAY, Zuhal; BİLGİN, AHMET; DOGAN, Berna

doi:10.3928/01913913-20150326-12

Spectral-Domain OCT Analyses of Macular Changes After Ranibizumab Therapy for Type 1 Retinopathy of Prematurity

Atıf İçin Kopyala

EROL M. K., COBAN D. T., OZDEMIR O., TUNAY Z. O., BİLGİN A. B., DOGAN B.

JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, cilt.52, sa.3, ss.152-158, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 52 Sayı: 3
Basım Tarihi: 2015
Doi Numarası: 10.3928/01913913-20150326-12
Dergi Adı: JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.152-158
Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose: To investigate the clinical and macular spectral-domain optical coherence tomography (SD-OCT) findings after intravitreal ranibizumab treatment for type 1 retinopathy of prematurity (ROP).